(MIVB) Amundi Index Solutions - Ratings and Ratios
Sustainable, Large-Cap, Europe, Equities, ETF
Description: MIVB Amundi Index Solutions
The Amundi MSCI Europe SRI PAB UCITS ETF DR C is an exchange-traded fund listed on XETRA with the ticker symbol MIVB, categorized under Europe Large-Cap Blend Equity. It is designed to track the performance of the MSCI Europe SRI PAB index, which comprises European large-cap stocks that meet specific environmental, social, and governance (ESG) criteria.
This ETF is a suitable investment option for those seeking exposure to European large-cap equities while adhering to sustainable and responsible investment principles. The funds assets under management (AUM) stand at approximately 1.62 billion EUR, indicating a significant investor base.
Key performance indicators (KPIs) to monitor for this ETF include its tracking error relative to the underlying index, expense ratio, and dividend yield. The funds performance is influenced by key economic drivers such as European economic growth, interest rates, and sector-specific trends. The ETFs focus on ESG criteria means that it is also sensitive to developments in sustainable investing and regulatory changes related to ESG reporting.
From a technical analysis perspective, the ETFs price action and moving averages suggest a potential trend reversal or consolidation phase. The current price is below its 20-day, 50-day, and 200-day simple moving averages (SMA20, SMA50, SMA200), indicating a possible downtrend. The average true range (ATR) is relatively low, suggesting stable trading conditions. Investors should monitor the ETFs price movements and trading volume to identify potential entry or exit points.
To further evaluate the investment potential of the Amundi MSCI Europe SRI PAB UCITS ETF DR C, investors should consider its correlation with other assets in their portfolio, as well as its historical performance during periods of market stress. A thorough analysis of the ETFs holdings and sector allocation can also provide insights into its potential risks and opportunities.
MIVB ETF Overview
| Market Cap in USD | 1,581m |
| Category | Europe Large-Cap Blend Equity |
| TER | 0.18% |
| IPO / Inception | 2018-09-11 |
MIVB ETF Ratings
| Growth Rating | 42.1% |
| Fundamental | - |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -17.8% |
| Analyst Rating | - |
MIVB Dividends
Currently no dividends paidMIVB Growth Ratios
| Growth Correlation 3m | -66.3% |
| Growth Correlation 12m | -17.9% |
| Growth Correlation 5y | 80.6% |
| CAGR 5y | 10.66% |
| CAGR/Max DD 3y | 0.68 |
| CAGR/Mean DD 3y | 5.00 |
| Sharpe Ratio 12m | -0.08 |
| Alpha | -16.84 |
| Beta | 0.626 |
| Volatility | 10.95% |
| Current Volume | 5.9k |
| Average Volume 20d | 3.9k |
| Stop Loss | 80.9 (-3.1%) |
| Signal | 1.09 |
What is the price of MIVB shares?
Over the past week, the price has changed by +0.69%, over one month by +1.15%, over three months by -3.01% and over the past year by -2.32%.
Is Amundi Index Solutions a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MIVB is around 77.76 EUR . This means that MIVB is currently overvalued and has a potential downside of -6.85%.
Is MIVB a buy, sell or hold?
What are the forecasts/targets for the MIVB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 86.6 | 3.7% |
MIVB Fundamental Data Overview
Market Cap EUR = 1.35b (1.35b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.35b EUR (1.35b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.35b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.35b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.35b)/V(0.0) * Re(8.32%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.32% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)